Simplex Trading
STML

Simplex Trading’s Stemline Therapeutics, Inc. STML Stock Holding History

Simplex Trading’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9
Closed -$4K – 8779
2020
Q1 		$4K Sell
9
-37
-80% -$240 ﹤0.01% 7018
2019
Q4 		$48K Buy
46
+30
+188% +$298 ﹤0.01% 5246
2019
Q3 		$16K Sell
16
-34
-68% -$445 ﹤0.01% 5986
2019
Q2 		$76K Buy
50
+30
+150% +$434 ﹤0.01% 4469
2019
Q1 		$25K Sell
20
-3
-13% -$34 ﹤0.01% 5575
2018
Q4 		$21K Buy
23
+12
+109% +$156 ﹤0.01% 5300
2018
Q3 		$18K Sell
11
-39
-78% -$625 ﹤0.01% 6059
2018
Q2 		$80K Buy
+50
New +$893 ﹤0.01% 4540
2017
Q4 		– Sell
-16
Closed -$2K – 7057
2017
Q3 		$2K Buy
+16
New +$150 ﹤0.01% 5261
2016
Q4 		– Sell
-17
Closed -$1K – 6855
2016
Q3 		$1K Buy
+17
New +$138 ﹤0.01% 5551
2015
Q2 		– Sell
-13
Closed -$6K – 6145
2015
Q1 		$6K Buy
13
+11
+550% +$168 ﹤0.01% 3417
2014
Q4 		$1K Buy
+2
New +$29 ﹤0.01% 4405

Simplex Trading's STML Position: Q2 2020 in Review

Simplex Trading sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 2,172 shares — an estimated $10K sold.

Simplex Trading first reported a position in STML in Q1 2016 and held it in 14 quarters. The position peaked at $344K in Q4 2018. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

  • Simplex Trading reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Simplex Trading sold 2,172 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $10K.
  • Simplex Trading first reported a position in Stemline Therapeutics, Inc. in Q1 2016 and held it in 14 quarters.
  • Simplex Trading's Stemline Therapeutics, Inc. position peaked at $344K in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Simplex Trading's 13F filing for Q2 2020, filed 13 Jul 2020.